Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Merck
Medtronic
Johnson and Johnson
Mallinckrodt

Last Updated: August 15, 2022

Lidocaine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for lidocaine hydrochloride and what is the scope of patent protection?

Lidocaine hydrochloride is the generic ingredient in thirty-five branded drugs marketed by Thea Pharma, Carlisle, Abbott, Abraxis Pharm, Afaxys, Akorn, Am Regent, Aspiro, B Braun Medical Inc, Bel Mar, Belmora Llc, Dell Labs, Elkins Sinn, Eugia Pharma, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Miles, Rising, Sintetica Sa, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Mylan Labs Ltd, Pharmaton, Meridian Medcl Techn, Astrazeneca, Dentsply Pharm, Bionpharma Inc, Sagent Pharms Inc, Cosette, Watson Labs Inc, Wockhardt Bio Ag, Actavis Mid Atlantic, Lannett Co Inc, Hikma, Kendall Il, Novitium Pharma, Paco, Pai Holdings Pharm, Powder Pharms, and Pfizer, and is included in one hundred and seven NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine hydrochloride has nineteen patent family members in ten countries.

There are nine drug master file entries for lidocaine hydrochloride. Forty-four suppliers are listed for this compound.

Summary for lidocaine hydrochloride
International Patents:19
US Patents:4
Tradenames:35
Applicants:49
NDAs:107
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 44
Raw Ingredient (Bulk) Api Vendors: 59
Clinical Trials: 1,661
Patent Applications: 5
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in lidocaine hydrochloride?lidocaine hydrochloride excipients list
DailyMed Link:lidocaine hydrochloride at DailyMed
Recent Clinical Trials for lidocaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Herlev and Gentofte HospitalPhase 3
Region Hovedstadens ApotekPhase 3
Bhupesh Parashar, MDPhase 2

See all lidocaine hydrochloride clinical trials

US Patents and Regulatory Information for lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca XYLOCAINE lidocaine hydrochloride INJECTABLE;INJECTION 010418-005 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Miles LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080414-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Astrazeneca XYLOCAINE 5% W/ GLUCOSE 7.5% lidocaine hydrochloride INJECTABLE;SPINAL 010496-002 Jul 7, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 See Plans and Pricing See Plans and Pricing
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 See Plans and Pricing See Plans and Pricing
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Moodys
Merck
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.